Researcher
Matthias Gijsen
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Sep 2016 → Today
Projects
1 - 3 of 3
- Antibacterial dose optimisation based on augmented renal clearance in adult critically ill patients and selected pediatric patientsFrom1 Oct 2021 → TodayFunding: BOF - postdoctoral mandates
- Beyond optimising drug exposure: Pharmacodynamic models to bridge the gap between exposure and response to antimicrobial treatmentsFrom15 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- ANTIBACTERIAL DOSING IN SPECIAL PATIENT POPULATIONS WITH SEVERE BACTERIAL INFECTIONS: A PATIENT-ORIENTED AND COVARIATE-DRIVEN APPROACHFrom1 Oct 2016 → 30 Sep 2021Funding: BOF - doctoral mandates, BOF - Doctoral projects
Publications
1 - 10 of 19
- Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function(2022)
Authors: Matthias Gijsen, Omar Elkayal, Pieter Annaert, Yves Debaveye, Joost Wauters, Erwin Dreesen, Isabel Spriet
Pages: 53 - 62Number of pages: 10 - Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia(2022)
Authors: Matthias Gijsen, Johan Maertens, Katrien Lagrou, Stefanie Desmet, Erwin Dreesen, Willy Peetermans, Yves Debaveye, Isabel Spriet
Number of pages: 6 - Pharmacokinetics of 2 oral paracetamol formulations in hospitalized octogenarians(2021)
Authors: Lorenz Van der Linden, Matthias Gijsen, Karel Allegaert, Pieter Annaert, Jos Tournoy
Pages: 1020 - 1030Number of pages: 11 - Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine(2021)
Authors: Matthias Gijsen, Dirk Vlasselaers, Karel Allegaert
Number of pages: 36 - Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients(2021)
Authors: Ruth Van Daele, Joost Wauters, Katrien Lagrou, Matthias Gijsen, Yves Debaveye
Number of pages: 12 - ANTIBACTERIAL DOSING IN SPECIAL PATIENT POPULATIONS WITH SEVERE BACTERIAL INFECTIONS: A PATIENT-ORIENTED AND COVARIATE-DRIVEN APPROACH(2021)
Authors: Matthias Gijsen, Isabel Spriet, Joost Wauters, Yves Debaveye, Pieter Annaert
- Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid(2021)
Authors: Ruth Van Daele, Joost Wauters, Matthias Gijsen, Pieter Annaert, Yves Debaveye, Katrien Lagrou, Willy Peetermans
Number of pages: 9 - Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis(2021)
Authors: Matthias Gijsen, Erwin Dreesen, Pieter Annaert, Yves Debaveye, Joost Wauters
Number of pages: 12 - Letter to the Editor regarding: Ceftriaxone exposure in patients undergoing extracorporeal membrane oxygenation(2021)
Authors: Matthias Gijsen, Pieter Annaert, Joost Wauters
Number of pages: 3 - Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study(2021)
Authors: Matthias Gijsen, Erwin Dreesen, Ruth Van Daele, Pieter Annaert, Yves Debaveye, Joost Wauters
Number of pages: 12